UX007G-CL202 is an open-label, single-arm, multi center extension study to assess the long-term safety and efficacy of UX007 in Glut 1 DS. The study will enroll up to 40 pediatric, adolescent and adult Glut 1 DS subjects who have completed the UX007G-CL201 study or participated in qualified ISTs.